Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Appointment of Director On October 29, 2025 , the board of directors (the “Board”) of Trupanion, Inc. (the “Company”) appointed Bradley S. Powell as a director. Mr. Powell, 65, served as Chief Financial Officer of Expeditors International of Washington, Inc. a publicly-traded global logistics company from October 2008 to September 2025. Prior to joining Expeditors, Mr. Powell served as Chief Financial Officer of Eden Bioscience Corporation, a publicly-traded biotechnology company, from July 1998 to September 2008, during which time he led the company through a successful initial public offering in 2000. He holds a B.S. in Accounting from Central Washington University. Mr. Powell was chosen to serve on the Board based on his accounting and financial acumen and his public company experience. Mr. Powell is an “independent director” under Nasdaq listing rule and he does not have any (i) arrangement or understanding with any person pursuant to which he was appointed as a member of the Board, (ii) family relationships with any of the Company’s directors or executive officers, or (iii) direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K. The Company has entered into its standard form of indemnification agreement with Mr. Powell, who will participate in the Company’s Compensation Program for Non-Employee Directors. Mr. Powell will serve for a term expiring at the annual meeting of stockholders held in 2026.
TRUP Trupanion, Inc. - 8-K
Accession
0001371285-25-0002385.029.01
Item 5.02 - Departure/Election of Directors or Certain Officers
252 words
Item 9.01 - Financial Statements and Exhibits
28 words
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press release dated October 30, 2025 104 Cover Page Interactive Data File (formatted as Inline XBRL)